Selected research
Industry Research
Transdermal Testosterone Industry Research Report 2026
Market perspective
The global Transdermal Testosterone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Transdermal Testosterone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Transdermal Testosterone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Transdermal Testosterone include Teva, AbbVie, Upsher-Smith Laboratories, Perrigo, Lupin, Endo Pharmaceuticals, Dr. Reddy's Laboratories, Cipla Inc. and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Transdermal Testosterone market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transdermal Testosterone Market by Company
Teva
AbbVie
Upsher-Smith Laboratories
Perrigo
Lupin
Endo Pharmaceuticals
Dr. Reddy's Laboratories
Cipla Inc.
Allergan
Acerus Pharmaceuticals
Transdermal Testosterone Segment by Type
Gel
Patch
Transdermal Testosterone Segment by Application
Late-Onset Hypogonadism
Hypogonadotropic Hypogonadism
Primary Hypogonadism
Transdermal Testosterone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Testosterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Testosterone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Testosterone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Testosterone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Testosterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gel
- Patch
Applications
- Late-Onset Hypogonadism
- Hypogonadotropic Hypogonadism
- Primary Hypogonadism
Companies covered
- Teva
- AbbVie
- Upsher-Smith Laboratories
- Perrigo
- Lupin
- Endo Pharmaceuticals
- Dr. Reddy's Laboratories
- Cipla Inc.
- Allergan
- Acerus Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transdermal Testosterone Market Size (2021-2032)
- 2.2.2 Global Transdermal Testosterone Sales (2021-2032)
- 2.2.3 Global Transdermal Testosterone Market Average Price (2021-2032)
- 2.3 Transdermal Testosterone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gel
- 2.3.3 Patch
- 2.4 Transdermal Testosterone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Late-Onset Hypogonadism
- 2.4.3 Hypogonadotropic Hypogonadism
- 2.4.4 Primary Hypogonadism
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transdermal Testosterone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transdermal Testosterone Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Transdermal Testosterone Revenue of Manufacturers (2021-2026)
- 3.4 Global Transdermal Testosterone Average Price by Manufacturers (2021-2026)
- 3.5 Global Transdermal Testosterone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transdermal Testosterone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transdermal Testosterone, Product Type & Application
- 3.8 Global Manufacturers of Transdermal Testosterone, Established Date
- 3.9 Global Transdermal Testosterone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Transdermal Testosterone Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 AbbVie
- 4.2.1 AbbVie Company Information
- 4.2.2 AbbVie Business Overview
- 4.2.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AbbVie Transdermal Testosterone Product Portfolio
- 4.2.5 AbbVie Recent Developments
- 4.3 Upsher-Smith Laboratories
- 4.3.1 Upsher-Smith Laboratories Company Information
- 4.3.2 Upsher-Smith Laboratories Business Overview
- 4.3.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio
- 4.3.5 Upsher-Smith Laboratories Recent Developments
- 4.4 Perrigo
- 4.4.1 Perrigo Company Information
- 4.4.2 Perrigo Business Overview
- 4.4.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Perrigo Transdermal Testosterone Product Portfolio
- 4.4.5 Perrigo Recent Developments
- 4.5 Lupin
- 4.5.1 Lupin Company Information
- 4.5.2 Lupin Business Overview
- 4.5.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lupin Transdermal Testosterone Product Portfolio
- 4.5.5 Lupin Recent Developments
- 4.6 Endo Pharmaceuticals
- 4.6.1 Endo Pharmaceuticals Company Information
- 4.6.2 Endo Pharmaceuticals Business Overview
- 4.6.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Endo Pharmaceuticals Transdermal Testosterone Product Portfolio
- 4.6.5 Endo Pharmaceuticals Recent Developments
- 4.7 Dr. Reddy's Laboratories
- 4.7.1 Dr. Reddy's Laboratories Company Information
- 4.7.2 Dr. Reddy's Laboratories Business Overview
- 4.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio
- 4.7.5 Dr. Reddy's Laboratories Recent Developments
- 4.8 Cipla Inc.
- 4.8.1 Cipla Inc. Company Information
- 4.8.2 Cipla Inc. Business Overview
- 4.8.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cipla Inc. Transdermal Testosterone Product Portfolio
- 4.8.5 Cipla Inc. Recent Developments
- 4.9 Allergan
- 4.9.1 Allergan Company Information
- 4.9.2 Allergan Business Overview
- 4.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Allergan Transdermal Testosterone Product Portfolio
- 4.9.5 Allergan Recent Developments
- 4.10 Acerus Pharmaceuticals
- 4.10.1 Acerus Pharmaceuticals Company Information
- 4.10.2 Acerus Pharmaceuticals Business Overview
- 4.10.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio
- 4.10.5 Acerus Pharmaceuticals Recent Developments
5 Global Transdermal Testosterone Market Scenario by Region
- 5.1 Global Transdermal Testosterone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transdermal Testosterone Sales by Region: 2021-2032
- 5.2.1 Global Transdermal Testosterone Sales by Region: 2021-2026
- 5.2.2 Global Transdermal Testosterone Sales by Region: 2027-2032
- 5.3 Global Transdermal Testosterone Revenue by Region: 2021-2032
- 5.3.1 Global Transdermal Testosterone Revenue by Region: 2021-2026
- 5.3.2 Global Transdermal Testosterone Revenue by Region: 2027-2032
- 5.4 North America Transdermal Testosterone Market Facts & Figures by Country
- 5.4.1 North America Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transdermal Testosterone Sales by Country (2021-2032)
- 5.4.3 North America Transdermal Testosterone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Transdermal Testosterone Market Facts & Figures by Country
- 5.5.1 Europe Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transdermal Testosterone Sales by Country (2021-2032)
- 5.5.3 Europe Transdermal Testosterone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Transdermal Testosterone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transdermal Testosterone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transdermal Testosterone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transdermal Testosterone Market Facts & Figures by Country
- 5.7.1 South America Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transdermal Testosterone Sales by Country (2021-2032)
- 5.7.3 South America Transdermal Testosterone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Transdermal Testosterone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transdermal Testosterone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transdermal Testosterone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Transdermal Testosterone Sales by Type (2021-2032)
- 6.1.1 Global Transdermal Testosterone Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Transdermal Testosterone Sales Market Share by Type (2021-2032)
- 6.2 Global Transdermal Testosterone Revenue by Type (2021-2032)
- 6.2.1 Global Transdermal Testosterone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transdermal Testosterone Revenue Market Share by Type (2021-2032)
- 6.3 Global Transdermal Testosterone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transdermal Testosterone Sales by Application (2021-2032)
- 7.1.1 Global Transdermal Testosterone Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Transdermal Testosterone Sales Market Share by Application (2021-2032)
- 7.2 Global Transdermal Testosterone Revenue by Application (2021-2032)
- 7.2.1 Global Transdermal Testosterone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transdermal Testosterone Revenue Market Share by Application (2021-2032)
- 7.3 Global Transdermal Testosterone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transdermal Testosterone Value Chain Analysis
- 8.1.1 Transdermal Testosterone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transdermal Testosterone Production Mode & Process
- 8.2 Transdermal Testosterone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transdermal Testosterone Distributors
- 8.2.3 Transdermal Testosterone Customers
9 Global Transdermal Testosterone Analyzing Market Dynamics
- 9.1 Transdermal Testosterone Industry Trends
- 9.2 Transdermal Testosterone Industry Drivers
- 9.3 Transdermal Testosterone Industry Opportunities and Challenges
- 9.4 Transdermal Testosterone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst